SU704456A3 - Способ получени -кетофосфонатов - Google Patents
Способ получени -кетофосфонатовInfo
- Publication number
- SU704456A3 SU704456A3 SU752182652A SU2182652A SU704456A3 SU 704456 A3 SU704456 A3 SU 704456A3 SU 752182652 A SU752182652 A SU 752182652A SU 2182652 A SU2182652 A SU 2182652A SU 704456 A3 SU704456 A3 SU 704456A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- ketophosphonates
- preparing beta
- solution
- temperature
- stirring
- Prior art date
Links
- 238000000034 method Methods 0.000 title description 6
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- NIWUMFULEUZEOT-UHFFFAOYSA-N O=P1OOO1 Chemical class O=P1OOO1 NIWUMFULEUZEOT-UHFFFAOYSA-N 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- -1 2-indanyl Chemical group 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- VONWDASPFIQPDY-UHFFFAOYSA-N dimethyl methylphosphonate Chemical compound COP(C)(=O)OC VONWDASPFIQPDY-UHFFFAOYSA-N 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- INDCQOTULGRLGI-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-2-yl)-2-dimethoxyphosphorylethanone Chemical compound C1=CC=C2CC(C(=O)CP(=O)(OC)OC)CC2=C1 INDCQOTULGRLGI-UHFFFAOYSA-N 0.000 description 1
- JZFOBTPKPKPPSX-UHFFFAOYSA-N 1-(2,3-dihydro-1h-inden-2-yl)-3-dimethoxyphosphorylpropan-2-one Chemical compound C1=CC=C2CC(CC(=O)CP(=O)(OC)OC)CC2=C1 JZFOBTPKPKPPSX-UHFFFAOYSA-N 0.000 description 1
- QDTUIHOOSMFIDM-UHFFFAOYSA-N 2-(5,6-dimethoxy-2,3-dihydro-1h-inden-1-yl)acetic acid Chemical compound C1=C(OC)C(OC)=CC2=C1C(CC(O)=O)CC2 QDTUIHOOSMFIDM-UHFFFAOYSA-N 0.000 description 1
- 125000004135 2-norbornyl group Chemical group [H]C1([H])C([H])([H])C2([H])C([H])([H])C1([H])C([H])([H])C2([H])* 0.000 description 1
- BBHJTCADCKZYSO-UHFFFAOYSA-N 4-(4-ethylcyclohexyl)benzonitrile Chemical compound C1CC(CC)CCC1C1=CC=C(C#N)C=C1 BBHJTCADCKZYSO-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 125000003262 carboxylic acid ester group Chemical class [H]C([H])([*:2])OC(=O)C([H])([H])[*:1] 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- DWHMMGGJCLDORC-UHFFFAOYSA-N methoxy(methyl)phosphinic acid Chemical compound COP(C)(O)=O DWHMMGGJCLDORC-UHFFFAOYSA-N 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C07C405/0008—Analogues having the carboxyl group in the side-chains replaced by other functional groups
- C07C405/0025—Analogues having the carboxyl group in the side-chains replaced by other functional groups containing keto groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/30—Compounds having groups
- C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C62/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C62/30—Unsaturated compounds
- C07C62/34—Unsaturated compounds containing ether groups, groups, groups, or groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4018—Esters of cycloaliphatic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
- C07F9/5407—Acyclic saturated phosphonium compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
Изобретение относитс к способу получени новых р-кетофосфонатов, которые могут найти, применение в фар мацевтической промышленности в качес не промежуточных веществ дл получени новых аналогов природных простагландйнов . Известен способ получени р-кетофосфонатов конденсацией фосфоната со сложным эфиром карбоновой кислоты в среде инертного органического раство рител в присутствии основани , например н-бутллити , при охлаждении, в атмосфере инертного газа. Целью изобретени вл етс раЗра ботка способа получени новых р-кетофосфонатов , простагландины на осно ве которых обладайт улучшенными свой ствами. Поставленна цель достигаетс спо собом получени (З-кетофосфонатов общей формулы 1 A-(CHj -c-CH-p: где А - циклоалкил С а- 1 адамантил , 2-норборнил, 2-Ц ,2,3,4-тетрагидронафтил ), незамещенный или замещенный галоидом, трифторметилом, низ шим алкилом или низшим алкоксилсэм 2- -инданил, п, - це-лое число 0-5, заключающийс в том, что диметилметилфосфонат подвергают взаимодействию со сложным эфиром общей формулы fl А - (CH2)ii COOAlK, где А и п, - имеют указанные значени , А1 к представл ет собой низший алкйл. Предложенный способ более подробно осуществл ют следующим образом. Раствор диметилметилфосфоната в тетрагидрофуране охлаждают до .-78°С в атмосфере сухого дзота, посл,е чего по капл м, постепенно добавл ют в него н-бутил.литий. После перемешивани покапл м добавл ют Сложный эфир форму.пы Г. После выдержки в течение 3-4 ч при температуре смеаь нагревают до комнатной температуры, нейтрализуют уксусной кислотой и выпаривают в роторн кГ испарителе до образовани белого гел . Желатинообразный материал экстра- гируют водой, после чего водную фазу экстрагируют хлороформом, органические экстракты собирают вместе, промывают, сушат и концентрируют с получением целевого продукта. Пример. Диметил-2-оксо-2- (2-инданил)этилфосфонат).
Раствор 20,4 г (164 глмол ) диме;тилметилфосфоната в 200 мл тетра гидрофурана охлаждают до 78° С в 5.тмосфере сухого азота В перемешива.емьай фосфонатный раствор добавл ют 82,6 мл 2,25 М раствора н-бутиллити в гексане по капл м в течение 20 кин с такой скоростью, при которой исключаетс возможность повышени температуры выше - 65°С, После дополнительного перемешивани в течфние 5 мин при -78°С по капл м со скоростью, позвол ющей поддерживать температуру ниже в течение 20 мин добавл ют 14,0 г (73,5 ммол ,6-диметокси-инданил-2 карб6к илата По истечении 1,0 ч выдержка при реакционной смеси даWT Нагретьс до комнатнойтемпера ,т ь|ры/ затем ее нейтрализуют 20 мл уг сусной кислоты и выпаривают в. роторном испарителе дообразовани белого гел . Желатинообразный материал экстрагируют 50 мл воды, водную фазу экстрагируют порци ми -по
Т. кип. с/мм. л рт. ст.
LC
о (0,2)
О
1 160-162 (0,2)
75 метиленхлорида (всего 4 порции), собирают органические экстракты, и промывают 75 мл. воды, высушивают над сульфатом магни и концентрируют в вакууме водоструйного насоса. Получают сырой остаток, который перегон ют т.кип. 150-160 С при 0,1 M|vi рт.ст) с получением 17,0 г (86,4/удиметил-2-оксО -2- (2--инданил) -этилфбсфоната.
На спектре ЯМР (CDCC, ) ;перегнанного продукта имелс синглет. 7,15сГдл ароматических протонов, дублет при 7,76(f(J-ll сПз) дл ОСН,. синглет при 3,25.cf дл бензиловьдх протонов, дублет при 3,18 cf ( D-23 сПз) дл РСНг и искаженный тр.иплет при 3,l8d ( 3 2 CJIa) дл СНСО.
Аналбгично примеру 1, использу соответствующие сложные, эфиры формулы 1 , получают целевые продукты формулы Г.
В таблице приведены температуры .кипени и данные ЯМР-спектроскопии полученн э1х продуктов.
6,73(ВЬ 3,.S6(S) 3,7B(d) 3,2,,2{d)
3,77(d)- 3,-06(cI), .2,,50(d)
209-212
(0,002)
3/70(d)f 2,93(d), 2,23(S)
195-200 (0,02)
3,75(d), 3,08(d), 2,53(n)
138-141 (0,3)
четкий Резонанс
,a
3,78(d)
3,05(3)
И p и м e p 2. Диметил-2-оксо-3- (2-инданил)пропилфосфонат..
Раствор 20,4 г (164 ммолей диметилметилфосфаната ) в 200 мл тетрагидрофурана охлаждают до в .атмосфере сухого азота. В перемешнва:емь1й фосфонатный раствор добавл ют 82,6 мл 2,25 М раствора н-бутиллити в гексане по капл м в теч .ение 20 мин с такой скоростью, при которой температура не превышает -65°С« После дополнительных 5 мин перемешивани при температуре по капл м добавл ют 14,0 г (77р5 ммол ) 5,6-диметокси-2-инданилацетата с такой скоростью, при. которой реак
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30475072A | 1972-11-08 | 1972-11-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU704456A3 true SU704456A3 (ru) | 1979-12-15 |
Family
ID=23177829
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU731978255A SU667131A3 (ru) | 1972-11-08 | 1973-12-07 | Способ получени производных простановой кислоты или их эпимеров |
| SU752182652A SU704456A3 (ru) | 1972-11-08 | 1975-12-23 | Способ получени -кетофосфонатов |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU731978255A SU667131A3 (ru) | 1972-11-08 | 1973-12-07 | Способ получени производных простановой кислоты или их эпимеров |
Country Status (20)
| Country | Link |
|---|---|
| JP (1) | JPS5714347B2 (ru) |
| AT (1) | AT345999B (ru) |
| BE (1) | BE807046A (ru) |
| CA (1) | CA1033727A (ru) |
| CH (1) | CH593930A5 (ru) |
| DE (1) | DE2355731C3 (ru) |
| DK (1) | DK143499C (ru) |
| ES (3) | ES420386A1 (ru) |
| FI (1) | FI58912C (ru) |
| FR (3) | FR2205338B1 (ru) |
| GB (1) | GB1456838A (ru) |
| IE (1) | IE40043B1 (ru) |
| IL (2) | IL50310A (ru) |
| IN (1) | IN139265B (ru) |
| NL (1) | NL7315307A (ru) |
| NO (2) | NO143663C (ru) |
| PH (2) | PH13261A (ru) |
| SE (4) | SE412229B (ru) |
| SU (2) | SU667131A3 (ru) |
| ZA (1) | ZA738595B (ru) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1431561A (en) * | 1973-01-31 | 1976-04-07 | Ici Ltd | Cyclopentane derivatives |
| US3929862A (en) * | 1974-01-08 | 1975-12-30 | Upjohn Co | Substituted tolylesters of PGF{HD 2{B {60 |
| JPS5823393B2 (ja) * | 1974-03-14 | 1983-05-14 | オノヤクヒンコウギヨウ カブシキガイシヤ | プロスタグランジンルイジカゴウブツ ノ セイゾウホウホウ |
| US4028396A (en) * | 1975-07-02 | 1977-06-07 | American Cyanamid Company | 16,16-Spirocycloalkyl prostaglandin derivatives |
| NZ183136A (en) * | 1976-02-11 | 1978-11-13 | Miles Lab | Monospiroalkyl derivatives of prostaclandis and pharmaceutical compositions |
| US4074063A (en) * | 1976-02-11 | 1978-02-14 | Miles Laboratories, Inc. | Bicycloalkyl derivatives of prostaglandins |
| US4404372A (en) * | 1977-06-13 | 1983-09-13 | Pfizer Inc. | 15-Substituted-ω-pentanorprostaglandin derivatives |
| DE2753995A1 (de) * | 1977-12-03 | 1979-06-07 | Bayer Ag | Neue bicycloalkenyl-prostaglandine und verfahren zu ihrer herstellung |
| US6048895A (en) * | 1997-09-09 | 2000-04-11 | The Procter & Gamble Company | Aromatic C16-C20 substituted tetrahydro prostaglandins useful as FP agonists |
| US5977173A (en) * | 1997-09-09 | 1999-11-02 | Wos; John August | Aromatic C16 -C20 -substituted tetrahydro prostaglandins useful as FP agonists |
| IL134792A0 (en) * | 1997-09-09 | 2001-04-30 | Procter & Gamble | Aromatic c16-c20-substituted tetrahydro prostaglandins useful as fp agonists |
| EP1159266B1 (en) * | 1999-03-05 | 2004-11-03 | Duke University | C-16 unsaturated fp-selective prostaglandins analogs |
| US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
| US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
| US20020037914A1 (en) | 2000-03-31 | 2002-03-28 | Delong Mitchell Anthony | Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins |
| ATE432910T1 (de) * | 2007-11-28 | 2009-06-15 | Bauer Maschinen Gmbh | Winde |
| US8623918B2 (en) | 2008-10-29 | 2014-01-07 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US8722739B2 (en) | 2008-10-29 | 2014-05-13 | Novaer Holdings, Inc. | Amino acid salts of prostaglandins |
| US20230097470A1 (en) * | 2021-08-23 | 2023-03-30 | Chirogate International Inc. | Processes and intermediates for the preparations of carboprost and carboprost tromethamine, and carboprost tromethamine prepared therefrom |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS4864073A (ru) * | 1971-04-30 | 1973-09-05 |
-
1973
- 1973-11-05 IL IL50310A patent/IL50310A/en unknown
- 1973-11-05 IL IL43571A patent/IL43571A/en unknown
- 1973-11-06 SE SE7315074A patent/SE412229B/xx unknown
- 1973-11-08 NL NL7315307A patent/NL7315307A/xx not_active Application Discontinuation
- 1973-11-08 NO NO4294/73A patent/NO143663C/no unknown
- 1973-11-08 CH CH1570773A patent/CH593930A5/xx not_active IP Right Cessation
- 1973-11-08 CA CA185,366A patent/CA1033727A/en not_active Expired
- 1973-11-08 AT AT941073A patent/AT345999B/de not_active IP Right Cessation
- 1973-11-08 DE DE2355731A patent/DE2355731C3/de not_active Expired
- 1973-11-08 IE IE2014/73A patent/IE40043B1/xx unknown
- 1973-11-08 PH PH15197A patent/PH13261A/en unknown
- 1973-11-08 GB GB5199773A patent/GB1456838A/en not_active Expired
- 1973-11-08 BE BE1005488A patent/BE807046A/xx unknown
- 1973-11-08 FI FI3455/73A patent/FI58912C/fi active
- 1973-11-08 FR FR7339758A patent/FR2205338B1/fr not_active Expired
- 1973-11-08 ZA ZA738595A patent/ZA738595B/xx unknown
- 1973-11-08 JP JP12584373A patent/JPS5714347B2/ja not_active Expired
- 1973-11-08 DK DK603373A patent/DK143499C/da active
- 1973-11-09 ES ES420386A patent/ES420386A1/es not_active Expired
- 1973-11-23 IN IN2583/CAL/73A patent/IN139265B/en unknown
- 1973-12-07 SU SU731978255A patent/SU667131A3/ru active
-
1974
- 1974-10-07 NO NO743616A patent/NO144385C/no unknown
-
1975
- 1975-12-23 SU SU752182652A patent/SU704456A3/ru active
-
1976
- 1976-01-16 ES ES444398A patent/ES444398A1/es not_active Expired
- 1976-01-29 FR FR7602434A patent/FR2291200A1/fr active Granted
- 1976-01-29 FR FR7602433A patent/FR2286147A1/fr active Granted
- 1976-05-25 PH PH18469A patent/PH13320A/en unknown
- 1976-11-03 SE SE7612262A patent/SE7612262L/xx not_active Application Discontinuation
- 1976-11-03 SE SE7612261A patent/SE7612261L/xx unknown
-
1977
- 1977-02-10 SE SE7701523A patent/SE417957B/xx unknown
- 1977-11-25 ES ES456279A patent/ES456279A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU704456A3 (ru) | Способ получени -кетофосфонатов | |
| KR20040072659A (ko) | 알콜 및 페놀의 수용성 포스포노옥시메틸 유도체를제조하는 방법 | |
| JPS5814433B2 (ja) | ガンマ−ピロン類合成の中間体およびその製造方法 | |
| Murphy et al. | Intramolecular termination of radical-polar crossover reactions | |
| Janecki et al. | A convenient Horner-Emmons approach to the synthesis of substituted ethyl 1, 3-butadiene-2-carboxylates, and related compounds | |
| CN110627827B (zh) | 4-乙炔基-四氢吡喃或4-乙炔基哌啶的合成方法 | |
| JPS63135395A (ja) | リン脂質誘導体及びその製造方法 | |
| JPS6310710B2 (ru) | ||
| CN114213611B (zh) | 一种吡喃[4,3-b]吡啶连接的共价有机框架材料及其合成方法 | |
| US4288642A (en) | Production of ω-alkene-1-ols | |
| US3894026A (en) | Production of thebaine | |
| JPH01125392A (ja) | メタンホスホン酸モノメチルエステルアンモニウム塩及びその製法 | |
| SU1033498A1 (ru) | Способ получени дигалогенангидридов 2-алкоксиалкенилфосфонистых кислот | |
| González-Bello et al. | Synthesis of tetrahydroquinolines, hexahydrobenzoindolizines and an aryl phosphonate linker for the generation of catalytic antibodies | |
| Morpain et al. | IMPROVED PREPARATION OF DI-O-ISOPROPYLIDENE-1, 2; 5, 6-D-MANNITOL | |
| KR930005008B1 (ko) | N-포스포노메틸글리신의 제조방법 | |
| SU1682358A1 (ru) | Способ получени фосфорилированных полуацеталей полуаминалей кетена | |
| SU410020A1 (ru) | ||
| Trofimov et al. | Addition of methyl mercaptoacetate to N-vinylpyrroles | |
| JPS6120529B2 (ru) | ||
| Binder et al. | Transannularly bridged di-µ 2-thiotetraborane (10). Dynamics, cis–trans-isomerism, reversible rearrangement: bis (diboranyl)‘butterfly’structure | |
| SU761495A1 (ru) | Способ получения растворимого полихлорфосфазена | |
| SU487891A1 (ru) | Способ получени алкиненфосфитов | |
| JPH0147475B2 (ru) | ||
| SU722900A1 (ru) | Способ получени алкиловых эфиров 2,3-дифинилинден-1-карбоновой кислоты |